Using the APP/PS1 model of AD-like pathology, we found diminished synaptic degeneration and improved behavioral and performance and learning after chronic inhibition of CSF1R with GW2580 (Olmos-Alonso et al., 2016). Here, APP is linked to Alzheimer disease.